GWAS |
- Coronary heart disease event reduction (statin therapy interaction) ( 22666496)
- Metabolite levels ( 23823483)
- Recurrent major depressive disorder ( 29317602)
|
- Alanine aminotransferase levels ( 33547301)
- Dysmenorrheic pain severity ( 29855537)
- Menstruation quality of life impact (dysmenorrhea) ( 29855537)
- Pain medicine use during menstruation ( 29855537)
- Pulmonary function ( 23932459)
- Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy) ( 24554482)
|